Roche lung cancer drug fails
March 3, 2014Research and Development, Sales and Marketing Cancer, MetMAb, NSCLC, Roche, Tarceva, avastin
An independent data monitoring committee has told Roche to halt a study of its experimental lung cancer drug MetMab due …
Xarelto lift for Bayer
March 3, 2014Manufacturing and Production, Sales and Marketing Bayer, Eylea, Stivarga, Xarelto, blood thinner, xofigo
Bayer Group says sales of its blood thinner Xarelto will be higher than it had predicted, with peak annual sales …
Cello unifies all its health agencies
March 3, 2014Medical Communications Cello, Cello Business Sciences, Insight Research Group, Mash Health Group, MedErgy HealthGroup, The MSI Consultancy
The Cello Group has unified all its health-orientated agencies in order to operate under one umbrella brand called Cello Health. …
GSK submits new Promacta licence
March 3, 2014Sales and Marketing GSK, NICE, Promacta, Revolade, blood, eltrombopag
GlaxoSmithKline is seeking a new licence for its blood disorder drug Promacta in patients with severe aplastic anaemia. Specifically, the …
dna Medical Communications hires MD
March 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dna Medical Communications, neil flash
Neil Flash has joined healthcare agency dna Medical Communications as the managing director for its UK team. Flash joined dna …
Look beyond the screen
March 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, cliinical, data, screening, trials
It makes sense, doesn’t it? You have a drug that’s effective for a certain disease, but no patients. What do …
Insurance firms ‘will not be sold records’
March 3, 2014Sales and Marketing GPs, HSCIC, Hunt, NHS, care data, care.data
The government is to pledge that insurance companies will not be sold patients’ health records via the care.data information sharing …
Government questions innovation uptake by doctors
February 28, 2014Medical Communications, Sales and Marketing ABPI, Hunt, NHS, PPRS, UK, doctors
The government has launched a consultation which aims to establish whether doctors are being held back from using innovative treatments, …
GSK’s Witty loses bonus over China scandal
February 28, 2014Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew
GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …
Packer Forbes Communications adds managing director
February 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Packer Forbes, joella webber
Comms agency Packer Forbes Communications is strengthening its leadership team by appointing Joella Webber as managing director. Webber who was …
NICE rejects Alimta
February 28, 2014Sales and Marketing Alimta, Cancer, NHS, NICE, NSCLC, lilly, pemetrexed
Eli Lilly is coming to terms with rejection by NICE after the cost watchdog said it would not recommend Alimta …
Novartis extends trial transparency
February 27, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency
Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.
MPs concerned about care.data
February 27, 2014Medical Communications, Sales and Marketing Dorrell, HSCIC, MPs, NHS, UK, care data, care.data, data
MPs have expressed concerns about security in the delayed NHS care.data programme which will see medical information routinely swapped between …
Novartis to axe Horsham site
February 27, 2014Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, closure, cuts, research, restructure
Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …
Biotech industry failed by UK, says UCB
February 27, 2014Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat
The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …
Best of Health Awards judges appointed
February 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Best of Health, IPA, henderson
The 2014 IPA Best of Health Awards which highlight the top creative advertising agencies in the industry has named the …
Mid Staffs to be ‘dissolved’
February 27, 2014Sales and Marketing Hunt, Mid Staffs, NHS, NHS England, tsas
The scandal-hit Mid Staffordshire NHS Foundation Trust is to be dissolved, after health secretary Jeremy Hunt accepted the recommendation of …
InterMune scores in lung trial
February 26, 2014Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung
InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …
BMS/AZ fat disorder drug gains FDA approval
February 26, 2014Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept
Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …
Bupa hires MHP Health head
February 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BUPA, gowrley, mhp health
Rupert Gowrley is leaving his role as joint head at MHP Health in order to start with Bupa as its …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
